Keurig Dr Pepper Reports Strong Start to 2020
BURLINGTON, Massachusetts and PLANO, Texas, April 27, 2020 /PRNewswire-HISPANIC PR WIRE/ — Keurig Dr Pepper Inc. (NYSE: KDP) today reported strong financial results for the first quarter ended March 31, 2020. Net sales in the first quarter of 2020 increased 4.4% to $2.61 billion, compared to $2.50 billion in the year-ago period, reflecting growth in all four reporting segments. On a constant currency basis, net sales increased 4.5%.
On a GAAP basis, diluted earnings per share in the first quarter of 2020 decreased to $0.11, compared to $0.16 in the year-ago period. Excluding items affecting comparability1, Adjusted diluted EPS advanced 16% to $0.29, compared to $0.25 in the year-ago period.
As previously announced, earlier this month the Company completed a strategic refinancing that extended its debt maturities and enhanced its liquidity profile, including a $1.5 billion senior notes issuance and the refinancing and upsizing of its 364-day revolving credit facility. The refinancing, which did not change the Company’s total debt balance or deleveraging commitments, increased KDP’s liquidity to a level that the Company believes will exceed its liquidity needs, even in the event of a protracted downturn.
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, “We delivered Q1 performance in line with our long-term targets, building on the business strength demonstrated since our merger in mid-2018 and setting us up for a strong 2020. However, we are now operating in a distinctly different environment that has required us to pivot significantly. The extraordinary steps we’ve taken to keep our teams safe and working, coupled with our broad portfolio and seven distinct routes to market, position us to continue to successfully navigate this unprecedented time. I recognize the significant role KDP employees are playing in our future success, and I can’t thank them enough for their tireless efforts to ensure we continue to meet the needs of our customers and consumers. Finally, while the timing of the macroeconomic recovery remains uncertain, we remain confident in our ability to deliver the guidance we reaffirmed today, particularly our Adjusted EPS and deleveraging commitments.”
First Quarter Consolidated Results
Net sales for the first quarter of 2020 increased 4.4% to $2.61 billion, compared to $2.50 billion in the year-ago period. On a constant currency basis, net sales advanced 4.5%, reflecting strong volume/mix growth of 5.0%, partially offset by lower net price realization of 0.5%. The volume/mix growth reflected particular strength in the Packaged Beverages segment, which included a benefit from the impact of COVID-19 late in the quarter, partially offset by slowdowns in the fountain foodservice business in the Beverage Concentrates segment and the away-from-home business in the Coffee Systems segment, both of which experienced an unfavorable impact from COVID-19 late in the quarter.
KDP in-market performance2 was very strong in the first quarter of 2020, with market share advancing in the majority of the Company’s key categories, including CSDs3, premium unflavored water, shelf stable fruit drinks and shelf stable apple juice and apple sauce. This performance reflected the strength of Dr Pepper and Canada Dry CSDs, CORE hydration and evian premium water, Snapple juice drinks and Motts apple juice and apple sauce. In coffee, retail consumption of single-serve pods manufactured by KDP grew over 6% in IRi tracked channels with dollar market share of KDP manufactured pods remaining strong at 81.0%.
Operating income decreased 6.4% to $466 million in the first quarter of 2020, compared to $498 million in the year-ago period, largely reflecting the unfavorable year-over-year impact of items affecting comparability, which includes an $86 million non-cash impairment charge on an equity investment. Also impacting the quarter was inflation, primarily in input costs and logistics, higher operating costs associated with increased consumer demand, tariffs, and the unfavorable comparison to a $10 million gain on the renegotiation of a manufacturing contract in the prior year. Partially offsetting these drivers were the benefits of productivity and merger synergies, which impacted both SG&A and cost of sales, the strong growth in net sales and a network optimization program gain of $42 million on the asset sale-leaseback of four facilities. Excluding items affecting comparability, Adjusted operating income increased 10.1% to $684 million, compared to $621 million in the year-ago period, and Adjusted operating margin advanced 140 basis points to 26.2%. On a constant currency basis, Adjusted operating income grew 10.5%.
Net income decreased 32% to $156 million, or $0.11 per diluted share, in the first quarter of 2020, compared to $230 million, or $0.16 per diluted share, in the year-ago period, meaningfully impacted by items affecting comparability. Excluding these items, Adjusted net income advanced 13% to $408 million in the first quarter of 2020, compared to $362 million in the year-ago period. This performance reflected the strong growth in Adjusted operating income, a lower Adjusted effective tax rate and lower Adjusted interest expense due to continued deleveraging, partially offset by a smaller gain in 2020 totaling $20 million from unwinding interest rate swap contracts versus the $27 million gain recorded in 2019. Adjusted diluted EPS advanced 16% to $0.29, compared to $0.25 in the year-ago period.
The Company generated strong free cash flow of approximately $464 million in the first quarter of 2020, enabling KDP to reduce bank debt by $42 million and repay $107 million of structured payables.
The Company’s management leverage ratio declined from 4.5x at year-end 2019 to 4.2x at the end of the first quarter of 2020, reflecting lower outstanding indebtedness and continued growth in Adjusted EBITDA, including the permanent benefit of adding certain amortization expenses not previously incorporated in the calculation of Adjusted EBITDA.
|
1 |
Adjusted financial metrics used in this release are non-GAAP. See reconciliations of GAAP results to Adjusted results in the accompanying tables. |
|
2 |
In-market performance (retail consumption; market share) based on Keurig Dr Pepper’s custom IRi category definitions. |
|
3 |
CSD refers to “Carbonated Soft Drink”. |
First Quarter Segment Results
Coffee Systems
Net sales for the first quarter of 2020 increased 0.5% to $973 million, compared to $968 million in the year-ago period, reflecting higher volume/mix of 3.7% and favorable foreign currency translation of 0.1%, partially offset by lower net price realization of 3.3% resulting from strategic price investments. The volume/mix increase of 3.7% reflected strong pod volume growth of 5.6%, despite a significant decline late in the quarter in the away-from-home coffee business due to both office closures and hospitality slowdown caused by COVID-19. Brewer volume declined 2.4% in the quarter, reflecting comparison to the double-digit growth recorded in the year-ago period, as well as the expected shift of brewer shipments from the first quarter to later in the year as a result of the timing impact of COVID-19 on brewer supply from certain regions in Asia.
Operating income declined 7.2% to $272 million in the first quarter of 2020, compared to $293 million in the year-ago period, reflecting the unfavorable year-over-year impact of items affecting comparability, strategic pricing, tariffs, and an increase in other operating costs. Partially offsetting these drivers were the benefits of continued productivity and merger synergies, a network optimization program gain of $16 million on the asset sale-leaseback of a manufacturing facility and the strong pod volume growth. Excluding items affecting comparability, Adjusted operating income in the quarter increased 3.6% to $347 million, compared to $335 million in the year-ago period, and Adjusted operating margin advanced 110 basis points to 35.7%.
Packaged Beverages
Net sales for the first quarter of 2020 advanced 9.1% to $1.22 billion, compared to $1.12 billion in the year-ago period, reflecting strong volume/mix growth of 8.7% and higher net price realization of 0.4%. The increase in volume/mix reflected strength in premium water, carbonated soft drinks, juice and apple sauce, partially driven by heightened consumer demand due to stock-up behavior late in the quarter related to COVID-19. Driving the net sales performance in the quarter were evian, Dr Pepper, Motts, Canada Dry, Core, A Shoc, A&W, 7UP and Squirt, as well as increased contract manufacturing.
Operating income increased approximately 27% to $189 million in the first quarter of 2020, compared to $149 million in the year-ago period, reflecting the strong net sales growth, continued productivity and merger synergies, and a network optimization program gain of $26 million on the asset sale-leaseback of three facilities. These growth drivers were partially offset by higher manufacturing costs to meet the surge in consumer demand late in the quarter, inflation in packaging, labor and logistics costs, the unfavorable comparison versus year-ago of a $10 million gain related to the renegotiation of a manufacturing contract, and an increase in other operating costs. Also impacting the comparison was a slight year-over-year impact of items affecting comparability. Excluding these items, Adjusted operating income increased 27% to $203 million, compared to $160 million in the year-ago period and Adjusted operating margin advanced 240 basis points to 16.7% of net sales.
Beverage Concentrates
Net sales for the first quarter of 2020 increased 0.7% to $306 million, compared to $304 million in the year-ago period, reflecting higher net price realization of 2.4%, partially offset by unfavorable volume/mix of 1.7%. The volume/mix decline reflected a significant channel shift away from on-premise business, which is shipped directly, as demand dropped off quickly late in the quarter due to COVID-19, partially offset by a slower build of the at-home business, as inventories in the Company’s partner bottling network were worked down.
Dr Pepper continued to demonstrate net sales strength in the quarter, partially offset by Crush. Shipment volume versus year-ago declined 2.4% in the first quarter of 2020, reflecting an immediate impact of COVID-19 on the fountain foodservice business late in the quarter, partially offset by growth in concentrate shipment volume for retail product. Bottler case sales increased 1.0% in the first quarter of 2020.
Operating income decreased 2.0% to $197 million in the first quarter of 2020, compared to $201 million in the year-ago period, reflecting the benefit of the net sales growth which was more than offset by higher marketing investments in the quarter. Operating margin decreased 170 basis points versus year-ago to 64.4%.
Latin America Beverages
Net sales for the first quarter of 2020 increased 0.9% to $117 million, compared to net sales of $116 million in the year-ago period, reflecting higher net price realization of 5.9% partially offset by unfavorable volume/mix of 0.7% and unfavorable foreign currency translation of 4.3%. On a constant currency basis, net sales increased 5.2% in the quarter.
Operating income increased to $27 million in the first quarter of 2020, compared to $11 million in the year-ago period, reflecting a favorable foreign currency transaction impact, the net sales growth, continued productivity and a modest year-over year benefit from items affecting comparability. Partially offsetting these growth drivers were inflation in input costs, manufacturing and logistics. Excluding items affecting comparability, Adjusted operating income more than doubled in the first quarter of 2020 to $27 million, compared to $12 million in the year-ago period, resulting in Adjusted operating margin advancing 1,280 basis points versus year-ago to 23.1%.
KDP Outlook for 2020
The impacts and volatility of COVID-19 are expected to be significant in 2020, and the timing and pacing of re-opening the economy and ultimately transitioning into what is likely to be a new normal are highly uncertain. Nevertheless, given the Company’s broad portfolio and unmatched distribution network that spans seven distinct routes to market, KDP is reaffirming its guidance for 2020.
Specifically, for the full-year 2020, KDP expects constant currency net sales growth in the range of 3% to 4%, with performance likely at the low end of the range. The Company expects full-year 2020 Adjusted diluted EPS growth in the range of 13% to 15%, or $1.38 to $1.40 per diluted share, given the significant visibility and control the Company maintains over its cost structure, including aggressive cost management, productivity programs and merger synergies. As such, the Company continues to expect its management leverage ratio in the range of 3.5x to 3.8x at year end 2020 and its management leverage ratio to be below 3.0x in two to three years from the July 2018 merger closing.
Investor Contacts:
Tyson Seely
Keurig Dr Pepper
T: 781-418-3352 / [email protected]
Steve Alexander
Keurig Dr Pepper
T: 972-673-6769 / [email protected]
Media Contact:
Katie Gilroy
Keurig Dr Pepper
T: 781-418-3345 / [email protected]
About Keurig Dr Pepper
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue in excess of $11 billion and nearly 26,000 employees. KDP holds leadership positions in soft drinks, specialty coffee and tea, water, juice and juice drinks and mixers, and markets the #1 single serve coffee brewing system in the U.S. and Canada. The Company’s portfolio of more than 125 owned, licensed and partner brands is designed to satisfy virtually any consumer need, any time, and includes Keurig®, Dr Pepper®, Green Mountain Coffee Roasters®, Canada Dry®, Snapple®, Bai®, Mott’s®, CORE® and The Original Donut Shop®. Through its powerful sales and distribution network, KDP can deliver its portfolio of hot and cold beverages to nearly every point of purchase for consumers. The Company is committed to sourcing, producing and distributing its beverages responsibly through its Drink Well. Do Good. corporate responsibility platform, including efforts around circular packaging, efficient natural resource use and supply chain sustainability. For more information, visit, www.keurigdrpepper.com.
FORWARD LOOKING STATEMENTS
Certain statements contained herein are “forward-looking statements” within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as “outlook,” “guidance,” “anticipate,” “expect,” “believe,” “could,” “estimate,” “feel,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would,” and similar words, phrases or expressions and variations or negatives of these words, although not all forward-looking statements contain these identifying words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the estimated or anticipated future results of the combined company following the combination of Keurig Green Mountain, Inc. (“KGM”) and Dr Pepper Snapple Group, Inc. (“DPSG” and such combination, the “transaction”), the anticipated benefits of the transaction, including estimated synergies and cost savings, the long-term merger targets, and other statements that are not historical facts. These statements are based on the current expectations of our management and are not predictions of actual performance.
These forward-looking statements are subject to a number of risks and uncertainties regarding the company’s business and the transaction and actual results may differ materially. These risks and uncertainties include, but are not limited to: (i) the impact the significant additional debt incurred in connection with the transaction may have on our ability to operate our business, (ii) risks relating to the integration of the KGM and DPS operations, products and employees into the combined company and assumption of certain potential liabilities of KGM and the possibility that the anticipated synergies and other benefits of the transaction, including cost savings, will not be realized or will not be realized within the expected timeframe, (iii) the impact of the global COVID-19 pandemic, and (iv) risks relating to the businesses and the industries in which our combined company operates. These risks and uncertainties, as well as other risks and uncertainties, are more fully discussed in the Company’s filings with the SEC, including our Annual Report on Form 10-K filed with the SEC on February 27, 2020, and our subsequent filings with the SEC. While the lists of risk factors presented here and in our public filings are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Any forward-looking statement made herein speaks only as of the date of this document. We are under no obligation to, and expressly disclaim any obligation to, update or alter any forward-looking statements, whether as a result of new information, subsequent events or otherwise, except as required by applicable laws or regulations.
NON-GAAP FINANCIAL MEASURES
This release includes certain non-GAAP financial measures including Adjusted operating income, Adjusted net income, Adjusted diluted EPS and Free Cash Flow, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies. Non-GAAP financial measures typically exclude certain charges, including one-time costs related to the transaction and integration activities, which are not expected to occur routinely in future periods. The Company uses non-GAAP financial measures internally to focus management on performance excluding these special charges to gauge our business operating performance. Management believes this information is helpful to investors because it increases transparency and assists investors in understanding the underlying performance of the Company and in the analysis of ongoing operating trends. Additionally, management believes that non-GAAP financial measures are frequently used by analysts and investors in their evaluation of companies, and its continued inclusion provides consistency in financial reporting and enables analysts and investors to perform meaningful comparisons of past, present and future operating results. The most directly comparable GAAP financial measures and reconciliations to non-GAAP financial measures are set forth in the appendix to this release and included in the Company’s filings with the SEC.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company’s control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others.
|
KEURIG DR PEPPER INC. |
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||
|
For the First Quarter of 2020 and 2019 |
|||||||
|
(Unaudited, in millions, except per share data) |
|||||||
|
First Quarter |
|||||||
|
(in millions, except per share data) |
2020 |
2019 |
|||||
|
Net sales |
$ |
2,613 |
$ |
2,504 |
|||
|
Cost of sales |
1,161 |
1,106 |
|||||
|
Gross profit |
1,452 |
1,398 |
|||||
|
Selling, general and administrative expenses |
1,028 |
911 |
|||||
|
Other operating income, net |
(42) |
(11) |
|||||
|
Income from operations |
466 |
498 |
|||||
|
Interest expense |
153 |
169 |
|||||
|
Loss on early extinguishment of debt |
2 |
9 |
|||||
|
Impairment on investment and note receivable |
86 |
— |
|||||
|
Other expense, net |
20 |
5 |
|||||
|
Income before provision for income taxes |
205 |
315 |
|||||
|
Provision for income taxes |
49 |
85 |
|||||
|
Net income |
$ |
156 |
$ |
230 |
|||
|
Earnings per common share: |
|||||||
|
Basic |
$ |
0.11 |
$ |
0.16 |
|||
|
Diluted |
0.11 |
0.16 |
|||||
|
Weighted average common shares outstanding: |
|||||||
|
Basic |
1,407.0 |
1,406.3 |
|||||
|
Diluted |
1,420.1 |
1,417.7 |
|||||
|
KEURIG DR PEPPER INC. |
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
As of March 31, 2020 and December 31, 2019 |
|||||||
|
(Unaudited, in millions, except shares and per share data) |
|||||||
|
March 31, |
December 31, |
||||||
|
(in millions, except share and per share data) |
2020 |
2019 |
|||||
|
Assets |
|||||||
|
Current assets: |
|||||||
|
Cash and cash equivalents |
$ |
197 |
$ |
75 |
|||
|
Restricted cash and restricted cash equivalents |
26 |
26 |
|||||
|
Trade accounts receivable, net |
1,037 |
1,115 |
|||||
|
Inventories |
682 |
654 |
|||||
|
Prepaid expenses and other current assets |
335 |
403 |
|||||
|
Total current assets |
2,277 |
2,273 |
|||||
|
Property, plant and equipment, net |
2,017 |
2,028 |
|||||
|
Investments in unconsolidated affiliates |
105 |
151 |
|||||
|
Goodwill |
19,898 |
20,172 |
|||||
|
Other intangible assets, net |
23,706 |
24,117 |
|||||
|
Other non-current assets |
811 |
748 |
|||||
|
Deferred tax assets |
29 |
29 |
|||||
|
Total assets |
$ |
48,843 |
$ |
49,518 |
|||
|
Liabilities and Stockholders’ Equity |
|||||||
|
Current liabilities: |
|||||||
|
Accounts payable |
$ |
3,238 |
$ |
3,176 |
|||
|
Accrued expenses |
960 |
939 |
|||||
|
Structured payables |
258 |
321 |
|||||
|
Short-term borrowings and current portion of long-term obligations |
1,957 |
1,593 |
|||||
|
Other current liabilities |
445 |
445 |
|||||
|
Total current liabilities |
6,858 |
6,474 |
|||||
|
Long-term obligations |
12,431 |
12,827 |
|||||
|
Deferred tax liabilities |
5,917 |
6,030 |
|||||
|
Other non-current liabilities |
997 |
930 |
|||||
|
Total liabilities |
26,203 |
26,261 |
|||||
|
Commitments and contingencies |
|||||||
|
Stockholders’ equity: |
|||||||
|
Preferred stock, $0.01 par value, 15,000,000 shares authorized, no shares issued |
— |
— |
|||||
|
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 1,407,079,951 and 1,406,852,305 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively |
14 |
14 |
|||||
|
Additional paid-in capital |
21,579 |
21,557 |
|||||
|
Retained earnings |
1,527 |
1,582 |
|||||
|
Accumulated other comprehensive (income) loss |
(480) |
104 |
|||||
|
Total stockholders’ equity |
22,640 |
23,257 |
|||||
|
Total liabilities and stockholders’ equity |
$ |
48,843 |
$ |
49,518 |
|||
|
KEURIG DR PEPPER INC. |
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
For The First Quarter of 2020 and 2019 |
|||||||
|
(Unaudited, in millions) |
|||||||
|
First Quarter |
|||||||
|
(in millions) |
2020 |
2019 |
|||||
|
Operating activities: |
|||||||
|
Net income |
$ |
156 |
$ |
230 |
|||
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||
|
Depreciation expense |
98 |
85 |
|||||
|
Amortization of intangibles |
33 |
31 |
|||||
|
Other amortization expense |
32 |
36 |
|||||
|
Provision for sales returns |
7 |
9 |
|||||
|
Deferred income taxes |
(5) |
1 |
|||||
|
Employee stock based compensation expense |
19 |
14 |
|||||
|
Loss on early extinguishment of debt |
2 |
9 |
|||||
|
Gain on disposal of property, plant and equipment |
(43) |
— |
|||||
|
Unrealized loss (gain) on foreign currency |
22 |
(17) |
|||||
|
Unrealized loss on derivatives |
43 |
7 |
|||||
|
Equity in losses of unconsolidated affiliates |
15 |
15 |
|||||
|
Impairment on investment and note receivable of unconsolidated affiliate |
86 |
— |
|||||
|
Other, net |
22 |
(4) |
|||||
|
Changes in assets and liabilities, net of effects of acquisition: |
|||||||
|
Trade accounts receivable |
42 |
126 |
|||||
|
Inventories |
(38) |
(36) |
|||||
|
Income taxes receivable, prepaid and payables, net |
(29) |
68 |
|||||
|
Other current and non current assets |
(179) |
(102) |
|||||
|
Accounts payable and accrued expenses |
150 |
125 |
|||||
|
Other current and non current liabilities |
(19) |
(6) |
|||||
|
Net change in operating assets and liabilities |
(73) |
175 |
|||||
|
Net cash provided by operating activities |
414 |
591 |
|||||
|
Investing activities: |
|||||||
|
Issuance of related party note receivable |
(6) |
(7) |
|||||
|
Purchases of property, plant and equipment |
(151) |
(62) |
|||||
|
Proceeds from sales of property, plant and equipment |
201 |
18 |
|||||
|
Purchases of intangibles |
(15) |
(2) |
|||||
|
Other, net |
5 |
8 |
|||||
|
Net cash provided by (used in) investing activities |
34 |
(45) |
|||||
|
Financing activities: |
|||||||
|
Proceeds from unsecured credit facility |
1,000 |
— |
|||||
|
Proceeds from term loan |
— |
2,000 |
|||||
|
Net (repayment) issuance of commercial paper |
(387) |
594 |
|||||
|
Proceeds from structured payables |
44 |
78 |
|||||
|
Payments on structured payables |
(107) |
(9) |
|||||
|
Payments on senior unsecured notes |
(250) |
(250) |
|||||
|
Repayment of term loan |
(405) |
(2,758) |
|||||
|
Payments on finance leases |
(13) |
(10) |
|||||
|
Cash dividends paid |
(212) |
(211) |
|||||
|
Other, net |
2 |
10 |
|||||
|
Net cash (used in) financing activities |
(328) |
(556) |
|||||
|
Cash, cash equivalents, restricted cash and restricted cash equivalents — net change from: |
|||||||
|
Operating, investing and financing activities |
120 |
(10) |
|||||
|
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents |
(8) |
10 |
|||||
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period |
111 |
139 |
|||||
|
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period |
$ |
223 |
$ |
139 |
|||
|
KEURIG DR PEPPER INC. |
|||||||
|
RECONCILIATION OF SEGMENT INFORMATION |
|||||||
|
(Unaudited) |
|||||||
|
First Quarter |
|||||||
|
(in millions) |
2020 |
2019 |
|||||
|
Net Sales |
|||||||
|
Coffee Systems |
$ |
973 |
$ |
968 |
|||
|
Packaged Beverages |
1,217 |
1,116 |
|||||
|
Beverage Concentrates |
306 |
304 |
|||||
|
Latin America Beverages |
117 |
116 |
|||||
|
Total net sales |
$ |
2,613 |
$ |
2,504 |
|||
|
Income from Operations |
|||||||
|
Coffee Systems |
$ |
272 |
$ |
293 |
|||
|
Packaged Beverages |
189 |
149 |
|||||
|
Beverage Concentrates |
197 |
201 |
|||||
|
Latin America Beverages |
27 |
11 |
|||||
|
Unallocated corporate costs |
(219) |
(156) |
|||||
|
Total income from operations |
$ |
466 |
$ |
498 |
|||
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(Unaudited)
The company reports its financial results in accordance with U.S. GAAP. However, management believes that certain non-GAAP financial measures that reflect the way management evaluates the business may provide investors with additional information regarding the company’s results, trends and ongoing performance on a comparable basis.
For the first quarter of 2020 and 2019, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger and Keurig Acquisition; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense attributable to the matching awards made to employees who made an initial investment in the Keurig Green Mountain, Inc. Executive Ownership Plan, the Keurig Dr Pepper Omnibus Incentive Plan of 2009 or the Keurig Dr Pepper Inc. Omnibus Incentive Plan of 2019; and (vi) other certain items that are excluded for comparison purposes to prior year periods.
Prior to the second quarter of 2019, we did not add back the amortization of the fair value adjustment of the senior unsecured debt recognized as a result of the purchase price allocation for the DPS Merger. As this item is similar to the amortization of intangibles, we changed our method of computing Adjusted results to exclude the amortization of the fair value adjustment of the senior unsecured notes in order to reflect how management views our business results on a consistent basis.
For the first quarter of 2020, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to the DPS Merger and the Keurig Acquisition; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) excluding the DPS Merger; (iv) costs related to significant nonroutine legal matters; (v) the loss on early extinguishment of debt related to the redemption of debt; (vi) incremental costs to our operations related to risks associated with the COVID-19 pandemic and (vii) impairment recognized on equity method investment with Bedford Systems, LLC.
Incremental costs to our operations related to risks associated with the COVID-19 pandemic include incremental expenses incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic. We believe removing these costs reflects how management views our business results on a consistent basis.
For the first quarter of 2019, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to the DPS Merger and the Keurig Acquisition; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) excluding the DPS Merger; (iv) costs related to significant nonroutine legal matters; (v) the impact of the step-up of acquired inventory not associated with the DPS Merger (vi) the loss on early extinguishment of debt related to the redemption of debt and (vii) the loss related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
For the first quarter of 2020 and 2019, the supplemental financial data set forth below includes reconciliations of Adjusted income from operations, Adjusted net income and Adjusted diluted EPS to the applicable financial measure presented in the unaudited condensed consolidated financial statement for the same period.
Reconciliations for these items are provided in the tables below.
|
KEURIG DR PEPPER INC. |
|||||||||||||||||||||
|
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS |
|||||||||||||||||||||
|
For the First Quarter Ended March 31, 2020 |
|||||||||||||||||||||
|
(Unaudited, in millions, except per share data) |
|||||||||||||||||||||
|
Cost of sales |
Gross profit |
Gross margin |
Selling, general |
Income from |
Operating margin |
||||||||||||||||
|
Reported |
$ |
1,161 |
$ |
1,452 |
55.6 |
% |
$ |
1,028 |
$ |
466 |
17.8 |
% |
|||||||||
|
Items Affecting Comparability: |
|||||||||||||||||||||
|
Mark to market |
(15) |
15 |
(43) |
58 |
|||||||||||||||||
|
Amortization of intangibles |
— |
— |
(33) |
33 |
|||||||||||||||||
|
Stock compensation |
— |
— |
(7) |
7 |
|||||||||||||||||
|
Restructuring and integration costs |
— |
— |
(52) |
52 |
|||||||||||||||||
|
Productivity |
(16) |
16 |
(38) |
54 |
|||||||||||||||||
|
Nonroutine legal matters |
— |
— |
(9) |
9 |
|||||||||||||||||
|
COVID-19 |
(1) |
1 |
(4) |
5 |
|||||||||||||||||
|
Adjusted GAAP |
$ |
1,129 |
$ |
1,484 |
56.8 |
% |
$ |
842 |
$ |
684 |
26.2 |
% |
|||||||||
|
Interest |
Loss on early |
Impairment |
Income |
Provision for |
Effective |
Net |
Weighted |
Diluted |
||||||||||||||||||||||||
|
Reported |
$ |
153 |
$ |
2 |
$ |
86 |
$ |
205 |
$ |
49 |
23.9 |
% |
$ |
156 |
1,420.1 |
$ |
0.11 |
|||||||||||||||
|
Items Affecting Comparability: |
||||||||||||||||||||||||||||||||
|
Mark to market |
(24) |
— |
— |
82 |
21 |
61 |
0.04 |
|||||||||||||||||||||||||
|
Amortization of intangibles |
— |
— |
— |
33 |
9 |
24 |
0.02 |
|||||||||||||||||||||||||
|
Amortization of deferred financing costs |
(3) |
— |
— |
3 |
1 |
2 |
— |
|||||||||||||||||||||||||
|
Amortization of fair value debt adjustment |
(6) |
— |
— |
6 |
2 |
4 |
— |
|||||||||||||||||||||||||
|
Stock compensation |
— |
— |
— |
7 |
1 |
6 |
— |
|||||||||||||||||||||||||
|
Restructuring and integration costs |
— |
— |
— |
52 |
14 |
38 |
0.03 |
|||||||||||||||||||||||||
|
Productivity |
— |
— |
— |
54 |
15 |
39 |
0.03 |
|||||||||||||||||||||||||
|
Loss on early extinguishment of debt |
— |
(2) |
— |
2 |
— |
2 |
— |
|||||||||||||||||||||||||
|
Impairment on investment |
— |
— |
(86) |
86 |
21 |
65 |
0.05 |
|||||||||||||||||||||||||
|
Nonroutine legal matters |
— |
— |
— |
9 |
2 |
7 |
— |
|||||||||||||||||||||||||
|
COVID-19 |
— |
— |
— |
5 |
1 |
4 |
— |
|||||||||||||||||||||||||
|
Adjusted GAAP |
$ |
120 |
$ |
— |
$ |
— |
$ |
544 |
$ |
136 |
25.0 |
% |
$ |
408 |
1,420.1 |
$ |
0.29 |
|||||||||||||||
|
Diluted earnings per common share may not foot due to rounding. |
|
KEURIG DR PEPPER INC. |
|||||||||||||||||||||
|
RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS |
|||||||||||||||||||||
|
For the First Quarter Ended March 31, 2019 |
|||||||||||||||||||||
|
(Unaudited, in millions, except per share data) |
|||||||||||||||||||||
|
Cost of sales |
Gross profit |
Gross |
Selling, general and |
Income from |
Operating |
||||||||||||||||
|
Reported |
$ |
1,106 |
$ |
1,398 |
55.8 |
% |
$ |
911 |
$ |
498 |
19.9 |
% |
|||||||||
|
Items Affecting Comparability: |
|||||||||||||||||||||
|
Mark to market |
(12) |
12 |
12 |
— |
|||||||||||||||||
|
Amortization of intangibles |
— |
— |
(31) |
31 |
|||||||||||||||||
|
Stock compensation |
— |
— |
(7) |
7 |
|||||||||||||||||
|
Restructuring and integration costs |
(1) |
1 |
(60) |
61 |
|||||||||||||||||
|
Productivity |
(3) |
3 |
(6) |
9 |
|||||||||||||||||
|
Nonroutine legal matters |
— |
— |
(7) |
7 |
|||||||||||||||||
|
Inventory step-up |
(3) |
3 |
— |
3 |
|||||||||||||||||
|
Malware incident |
(2) |
2 |
(3) |
5 |
|||||||||||||||||
|
Adjusted GAAP |
$ |
1,085 |
$ |
1,419 |
56.7 |
% |
$ |
809 |
$ |
621 |
24.8 |
% |
|||||||||
|
Interest |
Loss on early |
Other |
Income before |
Provision |
Effective |
Net income |
Weighted |
Diluted |
||||||||||||||||||||||||
|
Reported |
$ |
169 |
$ |
9 |
$ |
5 |
$ |
315 |
$ |
85 |
27.0 |
% |
$ |
230 |
1,417.7 |
$ |
0.16 |
|||||||||||||||
|
Items Affecting Comparability: |
||||||||||||||||||||||||||||||||
|
Mark to market |
(29) |
— |
2 |
27 |
7 |
20 |
0.01 |
|||||||||||||||||||||||||
|
Amortization of intangibles |
— |
— |
— |
31 |
8 |
23 |
0.02 |
|||||||||||||||||||||||||
|
Amortization of deferred financing costs |
(4) |
— |
— |
4 |
1 |
3 |
— |
|||||||||||||||||||||||||
|
Amortization of fair value debt adjustment |
(7) |
— |
— |
7 |
1 |
6 |
— |
|||||||||||||||||||||||||
|
Stock compensation |
— |
— |
— |
7 |
2 |
5 |
— |
|||||||||||||||||||||||||
|
Restructuring and integration costs |
— |
— |
— |
61 |
15 |
46 |
0.03 |
|||||||||||||||||||||||||
|
Productivity |
— |
— |
— |
9 |
2 |
7 |
— |
|||||||||||||||||||||||||
|
Transaction costs |
(5) |
— |
— |
5 |
1 |
4 |
— |
|||||||||||||||||||||||||
|
Loss on early extinguishment of debt |
— |
(9) |
— |
9 |
2 |
7 |
— |
|||||||||||||||||||||||||
|
Nonroutine legal matters |
— |
— |
— |
7 |
2 |
5 |
— |
|||||||||||||||||||||||||
|
Inventory step-up |
— |
— |
— |
3 |
1 |
2 |
— |
|||||||||||||||||||||||||
|
Malware incident |
— |
— |
— |
5 |
1 |
4 |
— |
|||||||||||||||||||||||||
|
Adjusted GAAP |
$ |
124 |
$ |
— |
$ |
7 |
$ |
490 |
$ |
128 |
26.1 |
% |
$ |
362 |
1,417.7 |
$ |
0.25 |
|||||||||||||||
|
Diluted earnings per common share may not foot due to rounding. |
|
KEURIG DR PEPPER INC. |
|||||||||||
|
RECONCILIATION OF SEGMENT ITEMS TO CERTAIN NON-GAAP ADJUSTED SEGMENT ITEMS |
|||||||||||
|
(Unaudited) |
|||||||||||
|
(in millions) |
Reported |
Items Affecting |
Adjusted |
||||||||
|
For the First Quarter Ended March 31, 2020 |
|||||||||||
|
Income from Operations |
|||||||||||
|
Coffee Systems |
$ |
272 |
$ |
75 |
$ |
347 |
|||||
|
Packaged Beverages |
189 |
14 |
203 |
||||||||
|
Beverage Concentrates |
197 |
— |
197 |
||||||||
|
Latin America Beverages |
27 |
— |
27 |
||||||||
|
Unallocated corporate costs |
(219) |
129 |
(90) |
||||||||
|
Total income from operations |
$ |
466 |
$ |
218 |
$ |
684 |
|||||
|
(in millions) |
Reported |
Items Affecting |
Adjusted |
||||||||
|
For the First Quarter Ended March 31, 2019 |
|||||||||||
|
Income from Operations |
|||||||||||
|
Coffee Systems |
$ |
293 |
$ |
42 |
$ |
335 |
|||||
|
Packaged Beverages |
149 |
11 |
160 |
||||||||
|
Beverage Concentrates |
201 |
— |
201 |
||||||||
|
Latin America Beverages |
11 |
1 |
12 |
||||||||
|
Unallocated corporate costs |
(156) |
69 |
(87) |
||||||||
|
Total income from operations |
$ |
498 |
$ |
123 |
$ |
621 |
|||||
|
KEURIG DR PEPPER INC. |
|||
|
RECONCILIATION OF ADJUSTED EBITDA AND MANAGEMENT LEVERAGE RATIO |
|||
|
(Unaudited) |
|||
|
(in millions, except for ratio) |
|||
|
ADJUSTED EBITDA RECONCILIATION – LAST TWELVE MONTHS |
|||
|
Net income |
$ |
1,180 |
|
|
Interest expense |
638 |
||
|
Provision for income taxes |
404 |
||
|
Loss on early extinguishment of debt |
4 |
||
|
Impairment on investment |
86 |
||
|
Other (income) expense, net |
34 |
||
|
Depreciation expense |
371 |
||
|
Other amortization |
170 |
||
|
Amortization of intangibles |
128 |
||
|
EBITDA |
$ |
3,015 |
|
|
Items affecting comparability: |
|||
|
Restructuring and integration expenses |
$ |
225 |
|
|
Transaction costs |
9 |
||
|
Productivity |
116 |
||
|
Nonroutine legal matters |
50 |
||
|
Stock compensation |
24 |
||
|
Malware incident |
3 |
||
|
Mark to market |
13 |
||
|
COVID-19 |
5 |
||
|
Adjusted EBITDA |
$ |
3,460 |
|
|
March 31, |
|||
|
2020 |
|||
|
Principal amounts of: |
|||
|
Commercial paper notes |
$ |
859 |
|
|
Term loan |
975 |
||
|
KDP Revolver |
1,000 |
||
|
Senior unsecured notes |
11,725 |
||
|
Total principal amounts |
14,559 |
||
|
Less: Cash and cash equivalents |
197 |
||
|
Total principal amounts less cash and cash equivalents |
$ |
14,362 |
|
|
March 31, 2020 Management Leverage Ratio |
4.2 |
||
|
KEURIG DR PEPPER INC. |
|||||||||||||||||||
|
RECONCILIATION OF ADJUSTED EBITDA – LAST TWELVE MONTHS |
|||||||||||||||||||
|
(Unaudited) |
|||||||||||||||||||
|
(in millions) |
SECOND |
THIRD |
FOURTH |
FIRST |
LAST |
||||||||||||||
|
Net income |
$ |
314 |
$ |
304 |
$ |
406 |
$ |
156 |
$ |
1,180 |
|||||||||
|
Interest expense |
170 |
158 |
157 |
153 |
638 |
||||||||||||||
|
Provision for income taxes |
102 |
109 |
144 |
49 |
404 |
||||||||||||||
|
Loss on early extinguishment of debt |
— |
— |
2 |
2 |
4 |
||||||||||||||
|
Impairment on investment |
— |
— |
— |
86 |
86 |
||||||||||||||
|
Other (income) expense, net |
1 |
9 |
4 |
20 |
34 |
||||||||||||||
|
Depreciation expense |
87 |
99 |
87 |
98 |
371 |
||||||||||||||
|
Other amortization |
54 |
46 |
38 |
32 |
170 |
||||||||||||||
|
Amortization of intangibles |
32 |
31 |
32 |
33 |
128 |
||||||||||||||
|
EBITDA |
$ |
760 |
$ |
756 |
$ |
870 |
$ |
629 |
$ |
3,015 |
|||||||||
|
Items affecting comparability: |
|||||||||||||||||||
|
Restructuring and integration expenses |
$ |
37 |
$ |
74 |
$ |
62 |
$ |
52 |
$ |
225 |
|||||||||
|
Transaction costs |
1 |
7 |
1 |
— |
9 |
||||||||||||||
|
Productivity |
20 |
34 |
20 |
42 |
116 |
||||||||||||||
|
Nonroutine legal matters |
8 |
12 |
21 |
9 |
50 |
||||||||||||||
|
Stock compensation |
8 |
3 |
6 |
7 |
24 |
||||||||||||||
|
Malware incident |
3 |
— |
— |
— |
3 |
||||||||||||||
|
COVID-19 |
— |
— |
— |
5 |
5 |
||||||||||||||
|
Mark to market |
(8) |
9 |
(46) |
58 |
13 |
||||||||||||||
|
Adjusted EBITDA |
$ |
829 |
$ |
895 |
$ |
934 |
$ |
802 |
$ |
3,460 |
|||||||||
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the first quarter of 2020 and 2019, there were no certain items excluded for comparison to prior year periods.
|
First Quarter |
||||||||
|
(in millions) |
2020 |
2019 |
||||||
|
Net cash provided by operating activities |
$ |
414 |
$ |
591 |
||||
|
Purchases of property, plant and equipment |
(151) |
(62) |
||||||
|
Proceeds from sales of property, plant and equipment |
201 |
18 |
||||||
|
Free Cash Flow |
$ |
464 |
$ |
547 |
||||
RECONCILIATION OF CERTAIN CURRENCY NEUTRAL ADJUSTED FINANCIAL RESULTS
(Unaudited)
Net sales, adjusted income from operations and adjusted earnings per share, as adjusted to currency neutral: These adjusted financial results are calculated on a currency neutral basis by converting our current-period local currency financial results using the prior-period foreign currency exchange rates.
|
For the First Quarter Ended March 31, 2020 |
|||||||||||||||
|
Coffee |
Packaged |
Beverage |
Latin America |
||||||||||||
|
Percent change |
Systems |
Beverages |
Concentrates |
Beverages |
Total |
||||||||||
|
Net sales |
0.5 |
% |
9.1 |
% |
0.7 |
% |
0.9 |
% |
4.4 |
% |
|||||
|
Impact of foreign currency |
(0.1) |
% |
— |
% |
— |
% |
4.3 |
% |
0.1 |
% |
|||||
|
Net sales, as adjusted to currency neutral |
0.4 |
% |
9.1 |
% |
0.7 |
% |
5.2 |
% |
4.5 |
% |
|||||
|
For the First Quarter Ended March 31, 2020 |
|||||||||||||||
|
Coffee |
Packaged |
Beverage |
Latin America |
||||||||||||
|
Percent change |
Systems |
Beverages |
Concentrates |
Beverages |
Total |
||||||||||
|
Adjusted income from operations |
3.6 |
% |
26.9 |
% |
(2.0) |
% |
125.0 |
% |
10.1 |
% |
|||||
|
Impact of foreign currency |
— |
% |
— |
% |
— |
% |
16.7 |
% |
0.4 |
% |
|||||
|
Adjusted income from operations, as adjusted to currency neutral |
3.6 |
% |
26.9 |
% |
(2.0) |
% |
141.7 |
% |
10.5 |
% |
|||||
|
For the First |
||
|
Adjusted diluted earnings per share |
$ |
0.29 |
|
Impact of foreign currency |
— |
|
|
Adjusted diluted earnings per share, as adjusted to currency neutral |
$ |
0.29 |

Logo – https://mma.prnewswire.com/media/724482/Keurig_Dr_Pepper_logo.jpg
SOURCE Keurig Dr Pepper Inc.
CIT Provides Investment to the Local Initiatives Support Corporation of San Diego
PASADENA, California, April 29, 2020 /PRNewswire-HISPANIC PR WIRE/ — CIT and its Pasadena-based banking subsidiary today announced a $3 million investment in support of the Local Initiatives Support Corporation of San Diego (LISC)’s Neighborhood Catalyst Fund. CIT’s investment is expected to help create 1,350 affordable housing units for low-to-moderate income residents of San Diego County.

“Building stronger, more equitable communities across San Diego is our priority, especially during this unprecedented time when many local residents need our support,” said Steve Solk, president of Consumer Banking for CIT. “Through this effort, we’re empowering local residents to achieve economic prosperity and a better quality of life.”
“LISC is grateful for CIT’s partnership as we work to drive transformative change across the region and serve neighborhoods of opportunity,” said Ricardo Flores, executive director for LISC San Diego. “This investment enables us to support and revitalize communities, broaden access to resources and improve the quality of life for thousands across Southern California.”
CIT’s support of the Neighborhood Catalyst Fund will result in multiple multi-family rental housing and mixed-use projects across San Diego County over the next decade Currently, the LISC San Diego Neighborhood Catalyst Fund has closed on its first loan of $5.5 million for a new 114-unit affordable housing project in City Heights, San Diego that is expected to open by 2023.
CIT actively supports and invests in affordable housing, economic development, neighborhood stabilization and core community services across its OneWest Bank and CIT Bank (formerly Mutual of Omaha Bank) branch banking footprint. Since 2016, CIT has invested more than $5 billion to advance affordable housing, economic development, education and access to credit for small businesses in Southern California.
About CIT
CIT is a leading national bank focused on empowering businesses and personal savers with the financial agility to navigate their goals. CIT Group Inc. (NYSE: CIT) is a financial holding company with over a century of experience and operates a principal bank subsidiary, CIT Bank, N.A. (Member FDIC, Equal Housing Lender). The company’s commercial banking segment includes commercial financing, community association banking, middle market banking, equipment and vendor financing, factoring, railcar financing, treasury and payments services, and capital markets and asset management. CIT’s consumer banking segment includes a national direct bank and regional branch network. Discover more at cit.com/about.
MEDIA RELATIONS:
Olivia Weiss
212-771-9657
[email protected]
Logo – https://mma.prnewswire.com/media/784850/CIT_Logo.jpg
SOURCE CIT Group Inc.
Clinical Trial Begins to See if Convalescent Plasma Can Treat COVID-19
Montefiore and Albert Einstein College of Medicine Partner with NYU Langone Health to Determine if Blood from COVID-19 Survivors Can Aid Current COVID-19 Patients
BRONX, N.Y., April 29, 2020 /PRNewswire-HISPANIC PR WIRE/ — Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating the disease.

The body’s immune response to viral infections includes making molecules called antibodies. Antibodies can combat the infection and possibly prevent reinfection in people—and may be successful for helping people who are sick with COVID-19 fight the virus. This therapy, known as convalescent plasma therapy, has been deployed in viral outbreaks over the past century, and has shown promise in reducing the severity of illness and improving survival rates.
The randomized controlled trial will enroll 300 people with COVID-19 respiratory symptoms. Half of these individuals will receive plasma that contains antibodies to the SARS-CoV-2 coronavirus, while the remaining half will receive a placebo. Candidates for the clinical trial have had respiratory symptoms for less than a week, require some supplemental oxygen or have been in the hospital for less than four days.
“We created this study based on evidence from the pre-antibiotic era, but there has been no scientific proof it is really effective,” said study co-leader Liise-anne Pirofski, M.D., chief of infectious diseases at Montefiore and Einstein and a leader of the national COVID-19 Convalescent Plasma Project.
Previous studies suggest that convalescent plasma may be helpful treatment for other coronaviruses, including SARS, but this trial aims to provide proof that it is effective for COVID-19 patients. Last month, Dr. Pirofski co-authored a widely cited viewpoint in the Journal of Clinical Investigation that championed the use of convalescent serum as a treatment for COVID-19.
Since the start of the pandemic, Montefiore has successfully treated and discharged approximately 4,000 severely ill COVID-19 patients from its hospitals. This presents an opportunity to get plasma from former patients and use these antibodies to treat a community disproportionally affected by COVID-19.
“Vaccines may not be available for more than a year. In the meantime, and given the lack of natural immunity and available vaccines, plasma therapy may help to provide the body what it needs to fight the infection,” said co-lead study investigator, Mila Ortigoza, MD, PHD, an instructor in the departments of Medicine and Microbiology at NYU Langone Health. “Infections like the new coronavirus that jump into humans from animals are dangerous because we have no antibodies against them, so we hope to learn if supplying them can save lives.”
The first Montefiore plasma donors came from Young Israel synagogue in New Rochelle. The community, which was home to one of the largest clusters of COVID-19 cases in the country, now represents a beacon of hope.
“To have so many people who have recovered from COVID-19 donate their plasma and make this research possible and potentially help people they have never met is an incredible celebration of the human spirit,” said Dr. Pirofski. “We are overwhelmed by the generosity of recovered patients and are confident this trial will help us learn if convalescent plasma is effective against COVID-19.”
About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.
About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.
Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg
SOURCE Montefiore Health System; Albert Einstein College of Medicine
The World Salsa Championship -“Salsa Olympics” Postpones its 6th Edition Due to COVID-19
ATLANTA, April 29, 2020 /PRNewswire-HISPANIC PR WIRE/ — The World Dance Group (WDG), producer of the World Salsa Championship, announced the postponement of the 6th Edition of the World Salsa Championship due to the Coronavirus pandemic. The event was scheduled for December 2-6, 2020 in San Juan, Puerto Rico and was expected to attract up to 8,000 participants.
Following the concerns about COVID-19, the World Dance Group has decided to postpone the 6th edition of the renowned World Salsa Championship (WSC).
The global pandemic has killed more than 213,273 people worldwide and sickened at least 3,063,814 according to Johns Hopkins University.
After rigorously vetting various city-hosting proposals through a competitive RFP process, the WDG management and logistics committee chose the historical city of San Juan, Puerto Rico to host the 6th edition of the WSC. Salsa is a music genre that has deep Puerto Rican roots and many of its stylistic features evolved from traditional Puerto Rican rhythms like the Bomba and Plena.
The event would have coincided with the 500th year anniversary of Old San Juan, a UNESCO World Heritage site and one of the top touristic destinations in the Caribbean. The competition brings together the world’s finest professional salsa dancers to showcase their technical and performance skills in group and individual competitions. The WSC was scheduled for December 2-6, 2020, and 8,000 people were expected to attend various activities such as the Salsa Championship, dance workshops, beach parties, and a major concert to celebrate the 500th anniversary of Old San Juan.
“The decision to postpone the World Salsa Championship in San Juan has been very difficult for me, particularly when today we celebrate the International Dance Day-as established by the Unesco in 1982. As a Puerto Rican, I always dream of returning to the island to celebrate with my people a world-class event such as the WSC. However, it is uncertain when live events will reopen according to authorities in Puerto Rico. Although the event is in December, the WSC is very unique because, like the Olympics, you have people coming from all over the world, plus it has qualifying regional events prior to the competition which have also been postponed or cancelled. The WDG will still invest in Puerto Rico by producing on-line content and sharing video streaming of events held on this beautiful island through the platforms SalZOOM.com and Dance-Challenge.com”, said Noel Roque, CEO of WDG.
About World Dance Group: The World Dance Group is an international organization, recognized as the producer of the World Salsa Championship, a competition that brings together professional Salsa dancers and fans from all over the world. WDC has been recipient of multiple awards since 2005. The Championship is broadcast by ESPN TV. The Competition has been successfully held five times in high profile cities like Las Vegas, Orlando (Disney), Miami and Atlanta.
For more information: https://www.worlddancegroup.com/
https://en.wikipedia.org/wiki/International_Dance_Day
Contact information: World Dance Group 1-404-402-1405, [email protected]
Photo – https://mma.prnewswire.com/media/1161351/IMG_20200327_WA0010.jpg
SOURCE World Dance Group
Fintech Acquires Armadillo Insight, LLC to Bring Actionable Intelligence to Alcohol Industry
TAMPA, Florida, April 28, 2020 /PRNewswire-HISPANIC PR WIRE/ — Financial Information Technologies, LLC (“Fintech”), the leading business solutions provider for the beverage alcohol industry, today announced that it has acquired Armadillo Insight, LLC, a company that turns complex craft beer data into sales and marketing intelligence that drives product placement across chain retailers. This acquisition furthers Fintech’s mission to deliver specialized technology that maximizes efficiency and improves communication across the three tiers of the alcohol industry.

With decades of experience as an electronic payment provider, Fintech solves the unique challenges of beverage alcohol management for 150,000 retailers and 4,000 distributors across the country. Fintech’s platform capabilities have expanded significantly since the company’s inception, evolving to provide business process automation and data-driven services for anyone who buys or sells alcohol. Adding Armadillo Insight to its portfolio of products brings actionable intelligence that enables sales growth for breweries. By integrating Armadillo Insight with the previously acquired Lilypad Solutions, Fintech will empower its rapidly growing base of nearly 500 supplier clients with an intelligent CRM solution.
“Armadillo Insight presents an exciting opportunity for Fintech to fortify and expand its services to the supplier market. Armadillo’s impressive ability to combine various data sets and derive mission-critical information combines perfectly with Fintech’s mission to offer technologies that drive operational efficiency and better align all businesses operating in the alcohol industry,” said Tad Phelps, Chief Executive Officer of Fintech. “We look forward to working with the Armadillo team, and we’re eager to expand on the strategic advancement that this acquisition affords our company.”
Since its founding in 2012, Armadillo Insight has served suppliers with task-specific, industry-relevant data. By combining depletion and competitive scan data, craft beer suppliers are able to improve productivity and increase their understanding of complex brand and package intelligence. Today, Armadillo Insight works with the industry’s top brands to provide an innovative data platform that drives sales growth.
“There is tremendous synergy between Fintech’s operational solutions and Armadillo Insight’s data solutions, which made it an easy decision to join forces,” stated Doug Mills, founder of Armadillo Insight. “We are proud of the developments that we have made since 2012, and we are honored to continue serving the industry’s top craft brands with Fintech’s technology and data science resources helping us innovate faster.”
This acquisition is the second within 12 months for Fintech and was completed in the first quarter of 2020. The Armadillo Insight team will integrate with Fintech, and all employees will continue their normal day-to-day operations as the partnership develops further.
About Fintech
Fintech is the leading business solutions provider for the beverage alcohol industry, empowering alcohol suppliers, distributors, and retailers with smart solutions that simplify beverage alcohol management. From product ordering and invoice payments, to sales strategy, business intelligence, and industry insights, Fintech continues to lead the development of technologies that increase margins and maximize operating efficiencies for anyone who sells alcohol. With decades of industry experience and unwavering dependability, Fintech connects over 600,000 business relationships nationwide. To learn more, visit www.fintech.com.
FINANCIAL-INFORMATION-TECHNOLOGIES, LLC. is the owner of the trademark FINTECH, the Stylized F Logo, and several other trademarks and service marks, many of which are registered at the U.S. Patent and Trademark Office. The underlying software behind the services offered by FINANCIAL-INFORMATION-TECHNOLOGIES, LLC and content of this website are ©2020 FINANCIAL-INFORMATION-TECHNOLOGIES, LLC. All rights reserved.
Contact: Misha Hart, 800.572.0854 x 3827, [email protected]
Follow @Fintech on Facebook, Twitter, and LinkedIn
Logo – https://mma.prnewswire.com/media/562037/Fintech_Logo.jpg
SOURCE Fintech
FlixLatino Available Free For One Month
MIAMI, April 28, 2020 /PRNewswire-HISPANIC PR WIRE/ — FlixLatino, the subscription video on demand service available in the United States and Puerto Rico will be offered free for 30 days. This incentive forms part of the efforts that SOMOS Next (part of the SOMOS Group’s companies) is doing to support home entertainment during these times. SOMOS Next’s digital platform offers content in Spanish in a variety of genres, and answers the demand, from audiences, to access more entertainment on television and electronic devices. FlixLatino is offering this free trial period without any contracts or obligations.

FlixLatino allows subscribers to enjoy the best of the Spanish cinema as well as series, documentaries and animation. The service includes the most recent series such as El Corazón del Océano, La Caza de Monteperdido, Más Hablar de Mambo, Secretos, including talent from the Iberoamerican industry such as Mario Casas, José Coronado, Gael García Bernal, Maribel Verdú, Diego Luna, Carlos Alcántara, among others. Its kids’ profile, FlixLatino Kids includes animation such as Little people, Doodleboo, Elías, Mouk and Los Doozers.
Luis Guillermo Villanueva, COO of SOMOS Next, stated: “We feel that as a business, we have the responsibility of supporting the population in this unique moment where entertainment at home and on various screens, is fundamental. This extended trial will allow people to, apart from testing our service, enjoy much-needed moments of recreation during quarantine.”
To take advantage of this special promotion, customers must enter the code QUEDATEENCASA through the website www.flixlatino.com.
Visitors who register on the FlixLatino website can do so until May 31 to enjoy the service for 30 days without any commitment.
About FlixLatino: FlixLatino is an SVOD service offering award-winning movies, series and documentaries originally produced in Spanish. FlixLatino’s movie catalog consists of contemporary theatrical releases from Latin America and Spain, displayed in HD quality. The service refreshes titles monthly, with weekly premieres, and continuously add new content to cater to subscriber’s demands. Enjoy a world of Spanish- language entertainment at your fingertips.
About SOMOS Next: SOMOS Next LLC is a wholly owned subsidiary of SOMOTV LLC, focused on the development and commercialization of audiovisual Spanish content in the online environment through all currently available windows. Its lineup includes a robust film library together with dynamic children programs among other genres. Its distribution is directed through the premium digital distributors taking advantage of their applications and other technologies, with access to platforms, mobile or fixed electronic devices.
Media Contact: Lucia Pineda, [email protected]
Photo – https://mma.prnewswire.com/media/1161074/Promotional_Code_QUEDATEENCASA.jpg
SOURCE SOMOS Next
Solis Health Plans and Florida Family Primary Care Centers to Offer COVID-19 Drive-Thru Testing at Six Center Locations in Tampa With Test Results Available in 48 Hours
TAMPA, Florida, April 28, 2020 /PRNewswire-HISPANIC PR WIRE/ — Solis Health Plans, a Medicare Advantage Plan, is joining with Florida Family Primary Care Centers to bring COVID-19 testing to senior citizens in Tampa beginning Monday, May 4, 2020. The testing will focus on residents aged 65 or older who are experiencing symptoms of the coronavirus. Test kits will be provided by CBS Labs. Testing will only be offered for those who have scheduled an appointment in advance by calling 813-461-7084. The call center opens at 9:00 a.m. daily and will remain open until the appointment slots for the following day are filled. The drive-thru testing will be available by appointment Monday through Friday between the hours of 8:00 am and 3:00 pm.

“We are pleased to be working with Florida Family Primary Care Centers to bring additional testing options to Tampa,” said Solis Health Plans CEO Daniel Hernandez. “This community is important to us, and we are proud to be a part of keeping Tampa safe.”
“Our partnership with Solis is essential for ensuring that Tampa seniors have access to coronavirus testing,” said Florida Family Primary Care Centers CEO Octavio “Butch” Bravo. “We invite those who are experiencing symptoms to schedule a test. The staff at our centers are prepared to take all necessary precautions to ensure your health and safety.”
Testing will take place at the following Florida Family Primary Care Centers locations:
- Pinellas – Pinellas Park (6245 66th Street, Pinellas Park, FL 33781)
- Hillsborough – Town & Country (6726 Hanley Road, Tampa, FL 33634)
- Hillsborough – Temple Terrace (11531 N 56th Street #103, Temple Terrace, FL 33617)
- Hillsborough – Palm River (7444 E. Palm River Rd, Tampa, FL 33619)
- Hillsborough – Plant City (1608 W. Oak Avenue, Plant City, FL 33563)
- Pasco – Hudson (7463 State Road 52, Hudson, FL 34667)
Individuals with an appointment should go to the confirmed center location at their scheduled time. An attendant will be outside to provide additional direction. ID is required for testing. Test results will be provided within 48 hours.
About Solis Health Plans
Solis Health Plans is a community-focused Florida Medicare Advantage health plan that delivers outstanding member experience and exceptional service to its members, providers, and brokers and offers competitive plans with expanded benefits in multiple counties. The company is locally based and self-identifies as the Un-Corporate Plan: personal as opposed to bureaucratic, innovative instead of risk-averse, and accountable rather than ambiguous. Solis Health Plans is committed to exceeding expectations and to being the plan of choice for the communities served, with the goal of achieving better healthcare outcomes.
For more information on Solis Health Plans, please visit www.solishealthplans.com.
Solis Health Plans is an HMO with a Medicare contract and a contract with the Florida Medicaid Program. Enrollment in Solis Health Plans depends on contract renewal.
About Florida Family Primary Care Centers
Florida Family Primary Care Centers (FFPCC) is a network of full-service family practice medical centers of dedicated, experienced healthcare professionals who believe in working with patients to prevent illness and injury and improve their overall health. Each medical professional comes to the practice with years of experience in their area of specialty. FFPCC works together to serve patients’ entire families for all medical needs in all stages of life. The centers’ healthcare professionals believe in providing comprehensive healthcare services to patients in a friendly, relaxed atmosphere.
For more information on Florida Family Primary Care Center, please visit www.floridafamilyprimarycarecenters.com.

Logo – https://mma.prnewswire.com/media/1033320/Solis_Logo_Logo.jpg
Logo – https://mma.prnewswire.com/media/1160643/fl_family_Logo.jpg
SOURCE Solis Health Plans, Inc.










